Biogen Idec (BIIB)
$292.15
0.68 (0.23%)
BIIB Stock Quote Delayed 30 Minutes
BIIB Stock Alert: What the Latest Alzheimer’s Drug Data Means for Biogen
Biogen (BIIB) stock is on the move Wednesday after the company provided the latest update on its Alzheimer's drug candidate.
11 Best Stocks to Buy for 2022
He found Apple at $1.49... Oracle at $0.51... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 11 Stocks for 2022 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
42.95B
PE Ratio
14.88
EPS
19.64
Volume (Avg. Vol.)
1.11M
Day's Range
$287.10 - $293.60
52-Week Range
$187.16 - $311.88
Dividend & Yield
N/A (N/A)
BIIB Stock Predictions, Articles, and Biogen Idec News
Hey Biogen Investors, Don’t Chase BIIB Stock!
If BIIB stock already reflects Biogen's early-stage Alzheimer's disease study results, then the next move could easily be to the downside.
Why Is Biogen (BIIB) Stock Up 40% Today?
Positive results from a clinical trial offer encouragement for the medical community, as well as for downtrodden BIIB stock investors.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.
Biogen (BIIB) Stock Dips Following Q2 Earnings Report
Biogen delivered a Q2 beat on the top and bottom lines, but a lack of important disclosures is hurting sentiment for BIIB stock.
BIIB Stock Treks Higher Amid News That Biogen CEO Michel Vounatsos Is Stepping Down
Drug-making giant Biogen is in the green today after announcing CEO Michel Vounatsos is stepping down from the role.
Biogen’s Aduhelm Crashes the Biotech Sector
Aduhelm is an Alzheimer's treatment, not a cure. Its quick approval and high price have set off pushback on the whole FDA and Medicare drug process.
Why Is Biogen (BIIB) Stock in the Spotlight Today?
Medicare's decision not to cover the cost of the drug maker's expensive Alzheimer's drug is hitting the company's stock price today.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! Let's get this party started with a dive into the biggest pre-market stock movers to watch for Wednesday!
4 Top Stock Trades for Friday: Ethereum, NIO, BIIB, BABA
Nio, Ethereum, Biogen and Alibaba were our top stock trades for Friday. Let's take a look at how the charts are setting up now.
BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders.
Biogen: Does Aduhelm Make it the Next Dendreon?
Aduhelm was approved by the FDA, priced at $56,000/year, but it isn't a cure for Alzheimer's.
